SPARKS — The Wound Care Center at Northern Nevada Medical Center recently acquired the SensiLase PAD-IQ Non-Invasive Vascular Tests technology. This technology allows the Wound Care Center to provide more comprehensive peripheral artery disease (PAD) detection. The SensiLase System allows physicians to assess arteries for tissue perfusion, accurately diagnose and quantify PAD, and predict healing potential using the skin perfusion pressure and the pulse volume recording technologies.

Peripheral artery disease is a slow, progressive condition that leads to narrowing and hardening of the arteries that supply blood to the legs and feet. This leads to decreased blood flow, which can injure nerves and other tissues. This problem occurs when fatty material (plaque) builds up on the walls of the arteries. Individuals with PAD can experience nerve and tissue damage as well as an increased risk of heart attack or stroke.

PAD is a common disorder that usually affects men over age 50, however anyone can be at higher risk if they have a history of abnormal cholesterol, diabetes, heart disease, high blood pressure, kidney disease involving hemodialysis, smoking or stroke.

For more information, call 352-5353.